China Pharma Holdings CPHI
NYSE CPHI
$0.53 -0.02 (-3.06%)
As of: Nov 11, 2026 · 10:20 AM EST

China Pharma Holdings (CPHI) Return on Sales [ROS] (2009 - 2026)

Updated

China Pharma Holdings (CPHI) recorded Return on Sales [ROS] of -150.98% in Q2 2026, down 87.41 percentage points from -63.57% a year earlier and down 37.39 percentage points from the prior quarter.

Analysis

China Pharma Holdings (CPHI) Return on Sales [ROS] (2009 - 2026) Analysis & Trends

On a TTM basis, China Pharma Holdings' Return on Sales [ROS] came in at -111.84% as of Jun 30, 2026, down 27.86 percentage points year-over-year; for FY2025, it came in at -78.16%, up 23.17 percentage points from FY2024.

  • Annual Return on Sales [ROS] has a five-year change of -54.43 percentage points (FY2020 to FY2025).
  • Across earlier years, Return on Sales [ROS] came in at -101.32% in FY2024 (-62.08 pp), -39.25% in FY2023 (+4.54 pp), -43.79% in FY2022 (-14.12 pp) and -29.67% in FY2021 (-5.94 pp).
  • The Q2 2026 figure is the lowest quarterly Return on Sales [ROS] since Q4 2019.
  • On a year-over-year basis, Return on Sales [ROS] rose in four of the last eight quarters, with an average year-over-year change of -16.69 percentage points.
  • Peak year-over-year performance for Return on Sales [ROS] in the last five years was a gain of 86.87 percentage points in Q2 2025, against a drop of 108.88 percentage points in Q2 2024 at the low end.
  • Per Business Quant, the preceding three quarters came in at -113.60% (Q1 2026), -97.90% (Q4 2025) and -83.06% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 34.46%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 24.35%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 36.01%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 30.74%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 29.12%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 35.79%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 41.71%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 32.98%
10 China Pharma Holdings 22.69 Mn 21.57 Mn 83,566.00 -150.98%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -150.98%
Mar 31, 2026 -113.60%
Dec 31, 2025 -97.90%
Sep 30, 2025 -83.06%
Jun 30, 2025 -63.57%
Mar 31, 2025 -66.76%
Dec 31, 2024 -105.47%
Sep 30, 2024 -98.65%
Jun 30, 2024 -150.44%
Mar 31, 2024 -66.87%
Dec 31, 2023 -55.10%
Sep 30, 2023 -39.57%
Jun 30, 2023 -41.56%
Mar 31, 2023 -20.28%
Dec 31, 2022 -40.02%
Sep 30, 2022 -35.03%
Jun 30, 2022 -48.33%
Mar 31, 2022 -56.84%
Dec 31, 2021 -22.45%
Sep 30, 2021 -38.53%
API Access

China Pharma Holdings Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=CPHI&period=max&api_key=YOUR_API_KEY